To determine whether lncRNA-GC1 levels were associated with the progression of GC, in the verification phase, we determined the levels of circulating exosomal lncRNA-GC1 in patients with different TNM stages and differentiation grades. The gene discussed is SOD2; the disease is gastric cancer.